[
  {
    "title": "海思科(002653.SZ)：获得创新药HSK40118片新药申请受理通知书",
    "href": "http://stock.jrj.com.cn/2023/01/04155937258402.shtml",
    "datetime": "2023-01-04 15:59:44",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：81万股限制性股票12月30日解锁上市",
    "href": "http://stock.jrj.com.cn/2022/12/26163637238213.shtml",
    "datetime": "2022-12-26 16:36:28",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟在开曼设立三级全资子公司 注册资本5万美元",
    "href": "http://stock.jrj.com.cn/2022/12/21165737228604.shtml",
    "datetime": "2022-12-21 16:57:23",
    "code": "002653"
  },
  {
    "title": "海思科控股股东范秀莲质押550万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2022/12/09191237202539.shtml",
    "datetime": "2022-12-09 19:12:11",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一范秀莲质押550万股",
    "href": "http://stock.jrj.com.cn/2022/12/09163537201746.shtml",
    "datetime": "2022-12-09 16:35:55",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK31858片Ⅱ期临床试验完成首例受试者入组和给药",
    "href": "http://stock.jrj.com.cn/2022/12/06170837192255.shtml",
    "datetime": "2022-12-06 17:08:05",
    "code": "002653"
  },
  {
    "title": "海思科控股股东王俊民质押962万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2022/11/30203137179383.shtml",
    "datetime": "2022-11-30 20:31:53",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：控股股东质押962万股",
    "href": "http://stock.jrj.com.cn/2022/11/30162737178257.shtml",
    "datetime": "2022-11-30 16:27:55",
    "code": "002653"
  },
  {
    "title": "海思科控股股东王俊民质押5291万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2022/11/18201137151251.shtml",
    "datetime": "2022-11-18 20:11:08",
    "code": "002653"
  },
  {
    "title": "海思科：HSK31858片II期临床试验获伦理批准",
    "href": "http://stock.jrj.com.cn/2022/11/16170437143912.shtml",
    "datetime": "2022-11-16 17:04:21",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK31858片Ⅱ期临床试验获得伦理批准",
    "href": "http://stock.jrj.com.cn/2022/11/16170337143929.shtml",
    "datetime": "2022-11-16 17:03:42",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK16149胶囊上市申请获受理",
    "href": "http://stock.jrj.com.cn/2022/11/08155737120363.shtml",
    "datetime": "2022-11-08 15:57:45",
    "code": "002653"
  },
  {
    "title": "海思科：创新药HSK16149胶囊上市申请获受理",
    "href": "http://stock.jrj.com.cn/2022/11/08155637120355.shtml",
    "datetime": "2022-11-08 15:56:58",
    "code": "002653"
  },
  {
    "title": "海思科：范秀莲所持2300万股解除质押 占公司总股本比例2.14%",
    "href": "http://stock.jrj.com.cn/2022/11/07180937117982.shtml",
    "datetime": "2022-11-07 18:09:12",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民质押2200万股",
    "href": "http://stock.jrj.com.cn/2022/11/01221837104866.shtml",
    "datetime": "2022-11-01 22:18:09",
    "code": "002653"
  },
  {
    "title": "海思科控股股东王俊民质押2200万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2022/11/01185037104177.shtml",
    "datetime": "2022-11-01 18:50:58",
    "code": "002653"
  },
  {
    "title": "海思科2022年前三季度净利1.03亿同比下滑62.54% 财务费用增长",
    "href": "http://stock.jrj.com.cn/2022/10/26191237086751.shtml",
    "datetime": "2022-10-26 19:12:15",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)第三季度净利3322.91万元 同比增长173.57%",
    "href": "http://stock.jrj.com.cn/2022/10/26185337086678.shtml",
    "datetime": "2022-10-26 18:53:42",
    "code": "002653"
  },
  {
    "title": "海思科：环泊酚注射液新适应症上市申请获得批准",
    "href": "http://stock.jrj.com.cn/2022/10/17170937060810.shtml",
    "datetime": "2022-10-17 17:09:59",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：环泊酚注射液新适应症上市申请获批",
    "href": "http://stock.jrj.com.cn/2022/10/17170537060818.shtml",
    "datetime": "2022-10-17 17:05:29",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民质押合计1286万股",
    "href": "http://stock.jrj.com.cn/2022/10/14162737056230.shtml",
    "datetime": "2022-10-14 16:27:27",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：环泊酚注射液第一项美国III期临床试验达到预设主要终点",
    "href": "http://stock.jrj.com.cn/2022/08/31155636958123.shtml",
    "datetime": "2022-08-31 15:56:05",
    "code": "002653"
  },
  {
    "title": "海思科2022年上半年净利6982.22万同比下滑78.2% 财务费用增加",
    "href": "http://stock.jrj.com.cn/2022/08/16211136905890.shtml",
    "datetime": "2022-08-16 21:11:38",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)半年度净利润6982.22万元、同比下降78.20%",
    "href": "http://stock.jrj.com.cn/2022/08/16171536904767.shtml",
    "datetime": "2022-08-16 17:15:44",
    "code": "002653"
  },
  {
    "title": "海思科控股股东范秀莲质押1100万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2022/07/22183036836474.shtml",
    "datetime": "2022-07-22 18:30:58",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一范秀莲质押1100万股",
    "href": "http://stock.jrj.com.cn/2022/07/22161536835880.shtml",
    "datetime": "2022-07-22 16:15:53",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民质押的合计1489.5111万股展期",
    "href": "http://stock.jrj.com.cn/2022/07/15160036815988.shtml",
    "datetime": "2022-07-15 16:00:43",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：环泊酚注射液新适应症上市申请获得批准",
    "href": "http://stock.jrj.com.cn/2022/07/14232636813412.shtml",
    "datetime": "2022-07-14 23:26:56",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：上半年净利预降74.08%-81.27%",
    "href": "http://stock.jrj.com.cn/2022/07/14171436811742.shtml",
    "datetime": "2022-07-14 17:14:41",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：注射用甲泼尼龙琥珀酸钠、氟哌噻吨美利曲辛片拟中选第七批国采",
    "href": "http://stock.jrj.com.cn/2022/07/13210136808915.shtml",
    "datetime": "2022-07-13 21:01:13",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：复方氨基酸(18AA)葡萄糖(15%)电解质注射液独家通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/07/07161936791026.shtml",
    "datetime": "2022-07-07 16:19:57",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：2021年年度权益分派10派1.8519元 股权登记日7月4日",
    "href": "http://stock.jrj.com.cn/2022/06/27172436761607.shtml",
    "datetime": "2022-06-27 17:24:21",
    "code": "002653"
  },
  {
    "title": "海思科：控股股东范秀莲所持1833万股被质押及1822万股解除质押",
    "href": "http://stock.jrj.com.cn/2022/06/10183036720161.shtml",
    "datetime": "2022-06-10 18:30:07",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：聚普瑞锌颗粒国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/05/25163836677732.shtml",
    "datetime": "2022-05-25 16:38:28",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟与关联法人对海思科控股集团合计增资3.58亿元",
    "href": "http://stock.jrj.com.cn/2022/05/08193036598126.shtml",
    "datetime": "2022-05-08 19:30:54",
    "code": "002653"
  },
  {
    "title": "海思科：非公开发行股票申请获得证监会核准批文",
    "href": "http://stock.jrj.com.cn/2022/05/05143836569240.shtml",
    "datetime": "2022-05-05 14:38:36",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：不超4000万股定增计划获批",
    "href": "http://stock.jrj.com.cn/2022/05/05115036567743.shtml",
    "datetime": "2022-05-05 11:50:41",
    "code": "002653"
  },
  {
    "title": "海思科2022年第一季度净利2620.32万同比下滑90.88% 上期收到单项政府补助",
    "href": "http://stock.jrj.com.cn/2022/05/03195036546693.shtml",
    "datetime": "2022-05-03 19:50:52",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)2021年度净利润降45.8%至3.45亿元 拟10派1.85元",
    "href": "http://stock.jrj.com.cn/2022/04/26203736478376.shtml",
    "datetime": "2022-04-26 20:37:47",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：定增申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2022/04/18164336385163.shtml",
    "datetime": "2022-04-18 16:43:13",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK29116美国临床试验申请获得许可",
    "href": "http://stock.jrj.com.cn/2022/04/14155636334880.shtml",
    "datetime": "2022-04-14 15:56:46",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟由四川海思科吸收合并红庆智地",
    "href": "http://stock.jrj.com.cn/2022/04/13162436324019.shtml",
    "datetime": "2022-04-13 16:24:34",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟注销全资子公司成都康信",
    "href": "http://stock.jrj.com.cn/2022/04/13162236324022.shtml",
    "datetime": "2022-04-13 16:22:59",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)获得创新药注射用HSK36273药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/04/10163936291816.shtml",
    "datetime": "2022-04-10 16:39:40",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：精氨酸谷氨酸注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/04/01155536247336.shtml",
    "datetime": "2022-04-01 15:55:28",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一范秀莲质押的1945万股展期",
    "href": "http://stock.jrj.com.cn/2022/03/25160235108640.shtml",
    "datetime": "2022-03-25 16:02:11",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得环泊酚注射液《药品补充申请批准通知书》",
    "href": "http://stock.jrj.com.cn/2022/03/24160434897706.shtml",
    "datetime": "2022-03-24 16:04:53",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：与Aquestive合作在中国开发和商业化ALS药物",
    "href": "http://stock.jrj.com.cn/2022/03/03161734516105.shtml",
    "datetime": "2022-03-03 16:17:07",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：证监会恢复审查公司定增申请",
    "href": "http://stock.jrj.com.cn/2022/02/23115234443111.shtml",
    "datetime": "2022-02-23 11:52:35",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK36212胶囊获批临床",
    "href": "http://stock.jrj.com.cn/2022/02/14164834344961.shtml",
    "datetime": "2022-02-14 16:48:54",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药环泊酚注射液新适应症注册申请获受理",
    "href": "http://stock.jrj.com.cn/2022/02/07162034301814.shtml",
    "datetime": "2022-02-07 16:20:07",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK31679片获批临床，治疗成人原发性高胆固醇血症",
    "href": "http://stock.jrj.com.cn/2022/02/07161334301785.shtml",
    "datetime": "2022-02-07 16:13:17",
    "code": "002653"
  },
  {
    "title": "海思科控股股东及实际控制人王俊民质押16.3万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2022/01/18191234170825.shtml",
    "datetime": "2022-01-18 19:12:13",
    "code": "002653"
  },
  {
    "title": "海思科：控股股东及实控人之一王俊民所持16.30万股质押 占公司总股本比例0.02%",
    "href": "http://stock.jrj.com.cn/2022/01/18130134169220.shtml",
    "datetime": "2022-01-18 13:01:16",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：控股股东王俊民补充质押16.3万股",
    "href": "http://stock.jrj.com.cn/2022/01/18115334168913.shtml",
    "datetime": "2022-01-18 11:53:25",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药注射用HSK36273临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/01/17164634164980.shtml",
    "datetime": "2022-01-17 16:46:28",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：控股股东王俊民质押317万股、质押展期910万股、解质1300万股",
    "href": "http://stock.jrj.com.cn/2021/12/20163134034701.shtml",
    "datetime": "2021-12-20 16:31:41",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：子公司获得创新药环泊酚注射液药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/12/13163634008812.shtml",
    "datetime": "2021-12-13 16:36:57",
    "code": "002653"
  },
  {
    "title": "海思科控股股东范秀莲质押2300万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2021/12/10183133995471.shtml",
    "datetime": "2021-12-10 18:31:59",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一范秀莲质押2300万股",
    "href": "http://stock.jrj.com.cn/2021/12/10163333994801.shtml",
    "datetime": "2021-12-10 16:33:27",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：环泊酚注射液被纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/06154833973762.shtml",
    "datetime": "2021-12-06 15:48:14",
    "code": "002653"
  },
  {
    "title": "海思科创新药环泊酚注射液被纳入国家医保目录 将有利于该产品市场推广及未来销售",
    "href": "http://stock.jrj.com.cn/2021/12/06142033973445.shtml",
    "datetime": "2021-12-06 14:20:07",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：控股股东王俊民质押展期2550万股",
    "href": "http://stock.jrj.com.cn/2021/12/01171033950322.shtml",
    "datetime": "2021-12-01 17:10:42",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得创新药环泊酚注射液受理通知书",
    "href": "http://stock.jrj.com.cn/2021/11/30163633944444.shtml",
    "datetime": "2021-11-30 16:36:48",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得创新药HSK31858片新药申请的受理通知书",
    "href": "http://stock.jrj.com.cn/2021/11/29160933938070.shtml",
    "datetime": "2021-11-29 16:09:19",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：向4名激励对象授予270万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/11/26163133923817.shtml",
    "datetime": "2021-11-26 16:31:43",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：控股股东王俊民质押479万股及质押展期984万股",
    "href": "http://stock.jrj.com.cn/2021/11/26161833923786.shtml",
    "datetime": "2021-11-26 16:18:27",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得创新药HSK31679片新药申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/11/16170233860700.shtml",
    "datetime": "2021-11-16 17:02:16",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一范秀莲补充质押745万股及质押的4665万股展期",
    "href": "http://stock.jrj.com.cn/2021/11/01170933798409.shtml",
    "datetime": "2021-11-01 17:09:23",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)第三季度净亏损4516.93万元",
    "href": "http://stock.jrj.com.cn/2021/10/29185333779053.shtml",
    "datetime": "2021-10-29 18:53:22",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)拟推320万股的2021年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/09/29185933537725.shtml",
    "datetime": "2021-09-29 18:59:01",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：注射用盐酸头孢替安国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/09/23163933504910.shtml",
    "datetime": "2021-09-23 16:39:53",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：丙泊酚中/长链脂肪乳注射液获批上市",
    "href": "http://stock.jrj.com.cn/2021/09/15163833439942.shtml",
    "datetime": "2021-09-15 16:38:46",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：签署一种长效治疗骨关节炎的候选首创新药Lorecivivint合作协议",
    "href": "http://stock.jrj.com.cn/2021/09/14145833433843.shtml",
    "datetime": "2021-09-14 14:58:39",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：注射用头孢美唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/09/08155133404211.shtml",
    "datetime": "2021-09-08 15:51:45",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：88.375万股限制性股票9月10日解禁",
    "href": "http://stock.jrj.com.cn/2021/09/07162533398701.shtml",
    "datetime": "2021-09-07 16:25:24",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得复方氨基酸(15AA-II)/葡萄糖(10%)电解质注射液药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/08/31164833361803.shtml",
    "datetime": "2021-08-31 16:48:34",
    "code": "002653"
  },
  {
    "title": "海思科2021年半年度净利3.2亿元 同比净利增加40.15%",
    "href": "http://stock.jrj.com.cn/2021/08/26195933326437.shtml",
    "datetime": "2021-08-26 19:59:14",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：全资子公司四川海思科拟对其控股子公司增资",
    "href": "http://stock.jrj.com.cn/2021/08/05201533208822.shtml",
    "datetime": "2021-08-05 20:15:02",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟出售DPP1抑制剂等四项相关专有技术所有权予新加坡公司",
    "href": "http://stock.jrj.com.cn/2021/08/05201033208792.shtml",
    "datetime": "2021-08-05 20:10:18",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：HSK21542注射液获准开展肝病瘙痒Ⅱ期临床试验",
    "href": "http://stock.jrj.com.cn/2021/08/02171533189672.shtml",
    "datetime": "2021-08-02 17:15:04",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)获得创新药HSK16149胶囊《药物临床试验批准通知书》",
    "href": "http://stock.jrj.com.cn/2021/08/01162133180671.shtml",
    "datetime": "2021-08-01 16:21:28",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：复方降压药培哚普利吲达帕胺片获批上市",
    "href": "http://stock.jrj.com.cn/2021/07/26162833152536.shtml",
    "datetime": "2021-07-26 16:28:24",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人王俊民、范秀莲解押2150万股",
    "href": "http://stock.jrj.com.cn/2021/07/23203333141805.shtml",
    "datetime": "2021-07-23 20:33:44",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一范秀莲解除质押1245万股",
    "href": "http://stock.jrj.com.cn/2021/07/21170333130424.shtml",
    "datetime": "2021-07-21 17:03:13",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：复方氨基酸注射液(18AA-Ⅶ)通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/07/21170133130413.shtml",
    "datetime": "2021-07-21 17:01:39",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得脂肪乳氨基酸(17)葡萄糖(11%)注射液补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2021/07/21165933130383.shtml",
    "datetime": "2021-07-21 16:59:30",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民质押1272.51万股",
    "href": "http://stock.jrj.com.cn/2021/07/19223533121135.shtml",
    "datetime": "2021-07-19 22:35:32",
    "code": "002653"
  },
  {
    "title": "海思科控股股东王俊民质押1272.51万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2021/07/19191233120301.shtml",
    "datetime": "2021-07-19 19:12:32",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：定增发行收到证监会行政许可申请受理单",
    "href": "http://stock.jrj.com.cn/2021/07/09195133071289.shtml",
    "datetime": "2021-07-09 19:51:31",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药环泊酚注射液Ⅲ期临床试验获伦理批准",
    "href": "http://stock.jrj.com.cn/2021/07/07164933058716.shtml",
    "datetime": "2021-07-07 16:49:56",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：收到产业扶持资金4909.52万元",
    "href": "http://stock.jrj.com.cn/2021/06/30183333022799.shtml",
    "datetime": "2021-06-30 18:33:50",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药环泊酚注射液新适应症注册申请获受理",
    "href": "http://stock.jrj.com.cn/2021/06/29173533016608.shtml",
    "datetime": "2021-06-29 17:35:32",
    "code": "002653"
  },
  {
    "title": "海思科：海思科在第五批国采中的中标品种有立适同-盐酸帕洛诺司琼注射液 中标价17.00元/支",
    "href": "http://stock.jrj.com.cn/2021/06/24172632990332.shtml",
    "datetime": "2021-06-24 17:26:08",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：3个产品拟中选第五批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2021/06/24160132989810.shtml",
    "datetime": "2021-06-24 16:01:27",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟将HSK29116散剂药物在中国内地以外市场的专有技术所有权转让给新加坡公司",
    "href": "http://stock.jrj.com.cn/2021/06/16194332942002.shtml",
    "datetime": "2021-06-16 19:43:52",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：15.6万股限制性股票将解除限售上市流通",
    "href": "http://stock.jrj.com.cn/2021/06/15174932935512.shtml",
    "datetime": "2021-06-15 17:49:32",
    "code": "002653"
  },
  {
    "title": "海思科：关于环泊酚医保工作方面 公司正在积极做医保谈判的准备工作",
    "href": "http://stock.jrj.com.cn/2021/06/08070432890595.shtml",
    "datetime": "2021-06-08 07:04:57",
    "code": "002653"
  },
  {
    "title": "海思科：部分限制性股票回购注销完成",
    "href": "http://stock.jrj.com.cn/2021/06/07161732887289.shtml",
    "datetime": "2021-06-07 16:17:05",
    "code": "002653"
  },
  {
    "title": "海思科：环泊酚的医院开发正常推进中 目前已拓展医院近百家 其中三级医院近50家",
    "href": "http://stock.jrj.com.cn/2021/06/02162532863448.shtml",
    "datetime": "2021-06-02 16:25:33",
    "code": "002653"
  },
  {
    "title": "海思科：公司积极优化产业结构和布局 不断推动能源消费结构转型",
    "href": "http://stock.jrj.com.cn/2021/06/01185032858510.shtml",
    "datetime": "2021-06-01 18:50:50",
    "code": "002653"
  },
  {
    "title": "海思科：公司目前经营情况一切正常",
    "href": "http://stock.jrj.com.cn/2021/06/01184932858496.shtml",
    "datetime": "2021-06-01 18:49:47",
    "code": "002653"
  },
  {
    "title": "海思科：本次非公开发行股票的定价基准日为发行期首日",
    "href": "http://stock.jrj.com.cn/2021/05/31152632849402.shtml",
    "datetime": "2021-05-31 15:26:21",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟转让同惠66号定向资产管理计划委托资产份额权益",
    "href": "http://stock.jrj.com.cn/2021/05/31150732849187.shtml",
    "datetime": "2021-05-31 15:07:36",
    "code": "002653"
  },
  {
    "title": "海思科：公司目前没有海外订单",
    "href": "http://stock.jrj.com.cn/2021/05/27160132830046.shtml",
    "datetime": "2021-05-27 16:01:58",
    "code": "002653"
  },
  {
    "title": "海思科：公司HSK3486在美国的3期临床进展顺利",
    "href": "http://stock.jrj.com.cn/2021/05/27153132829626.shtml",
    "datetime": "2021-05-27 15:31:26",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民解押620万股",
    "href": "http://stock.jrj.com.cn/2021/05/24155332810662.shtml",
    "datetime": "2021-05-24 15:53:19",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：中长链脂肪乳/氨基酸(16)/葡萄糖(16%)注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/17163832769501.shtml",
    "datetime": "2021-05-17 16:38:39",
    "code": "002653"
  },
  {
    "title": "海思科：麻醉及镇痛是公司的重点领域",
    "href": "http://stock.jrj.com.cn/2021/05/14185532756646.shtml",
    "datetime": "2021-05-14 18:55:48",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民解押1240万股",
    "href": "http://stock.jrj.com.cn/2021/05/12162232742341.shtml",
    "datetime": "2021-05-12 16:22:04",
    "code": "002653"
  },
  {
    "title": "海思科控股股东范秀莲质押1400万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2021/05/10200832731528.shtml",
    "datetime": "2021-05-10 20:08:38",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一范秀莲质押1400万股",
    "href": "http://stock.jrj.com.cn/2021/05/10161932729914.shtml",
    "datetime": "2021-05-10 16:19:15",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：中/长链脂肪乳注射液(C6-24)通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/06172932702073.shtml",
    "datetime": "2021-05-06 17:29:32",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)一季度净利润升123.76%至2.87亿元",
    "href": "http://stock.jrj.com.cn/2021/04/27214932465728.shtml",
    "datetime": "2021-04-27 21:49:51",
    "code": "002653"
  },
  {
    "title": "海思科：“两票制”实施后公司产品直接向终端销售",
    "href": "http://stock.jrj.com.cn/2021/04/27131932461809.shtml",
    "datetime": "2021-04-27 13:19:40",
    "code": "002653"
  },
  {
    "title": "海思科：公司的吸入技术平台具备粉雾剂、吸入溶液和鼻喷剂这几种制剂的开发能力",
    "href": "http://stock.jrj.com.cn/2021/04/20170832410550.shtml",
    "datetime": "2021-04-20 17:08:23",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)2020年度权益分派10派3.72元 股权登记日为4月27日",
    "href": "http://stock.jrj.com.cn/2021/04/20155832410004.shtml",
    "datetime": "2021-04-20 15:58:43",
    "code": "002653"
  },
  {
    "title": "海思科：第五批国家组织药品带量采购正式启动 本公司本次药品国采涉及三个品种",
    "href": "http://stock.jrj.com.cn/2021/04/19163632402457.shtml",
    "datetime": "2021-04-19 16:36:26",
    "code": "002653"
  },
  {
    "title": "海思科：我公司不存在使用虚假发票、票据套取资金的行为",
    "href": "http://stock.jrj.com.cn/2021/04/16121932385606.shtml",
    "datetime": "2021-04-16 12:19:28",
    "code": "002653"
  },
  {
    "title": "海思科2021年第一季度预计净利2.6亿-2.9亿 同比增长104%-128%",
    "href": "http://stock.jrj.com.cn/2021/04/13224532367413.shtml",
    "datetime": "2021-04-13 22:45:09",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)一季度净利预增103.59%-128.20%",
    "href": "http://stock.jrj.com.cn/2021/04/13164332365440.shtml",
    "datetime": "2021-04-13 16:43:15",
    "code": "002653"
  },
  {
    "title": "旗下静脉麻醉创新药相比原研药不具价格优势 海思科：值得更高定价",
    "href": "http://stock.jrj.com.cn/2021/04/12205832359632.shtml",
    "datetime": "2021-04-12 20:58:57",
    "code": "002653"
  },
  {
    "title": "海思科：公司心血管主要产品因市场环境有较大变化等原因 2020年销售额同比有较大下降",
    "href": "http://stock.jrj.com.cn/2021/04/07165432325765.shtml",
    "datetime": "2021-04-07 16:54:27",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK29116散临床试验获得批准",
    "href": "http://stock.jrj.com.cn/2021/04/06162932319314.shtml",
    "datetime": "2021-04-06 16:29:15",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得精氨酸谷氨酸注射液的受理通知书",
    "href": "http://stock.jrj.com.cn/2021/04/06152232319054.shtml",
    "datetime": "2021-04-06 15:22:21",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：注射用甲泼尼龙琥珀酸钠通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/06152032319046.shtml",
    "datetime": "2021-04-06 15:20:27",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一范秀莲质押1945万股",
    "href": "http://stock.jrj.com.cn/2021/03/28201532231167.shtml",
    "datetime": "2021-03-28 20:15:30",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：用于治疗勃起功能障碍(ED)的阿伐那非片获批上市",
    "href": "http://stock.jrj.com.cn/2021/03/28201432231165.shtml",
    "datetime": "2021-03-28 20:14:07",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民参与的信托计划减持231万股",
    "href": "http://stock.jrj.com.cn/2021/03/28200932231159.shtml",
    "datetime": "2021-03-28 20:09:16",
    "code": "002653"
  },
  {
    "title": "海思科：创新药HSK21542注射液Ⅲ期临床试验方案获CDE同意",
    "href": "http://stock.jrj.com.cn/2021/03/28163532230072.shtml",
    "datetime": "2021-03-28 16:35:42",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK21542注射液Ⅲ期临床试验方案获得CDE同意",
    "href": "http://stock.jrj.com.cn/2021/03/28163332230067.shtml",
    "datetime": "2021-03-28 16:33:06",
    "code": "002653"
  },
  {
    "title": "海思科2020年净利增长28.9% 董事长王俊民薪酬109.82万",
    "href": "http://stock.jrj.com.cn/2021/03/24225532211389.shtml",
    "datetime": "2021-03-24 22:55:47",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：2020年度净利升28.9%至6.37亿元 拟10派3.72元",
    "href": "http://stock.jrj.com.cn/2021/03/24205432210923.shtml",
    "datetime": "2021-03-24 20:54:19",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟使用不超6亿元自有资金购买保本型理财产品",
    "href": "http://stock.jrj.com.cn/2021/03/24205332210918.shtml",
    "datetime": "2021-03-24 20:53:36",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟在不超3.5亿元额度内使用部分闲置自有资金购买非保本型理财产品",
    "href": "http://stock.jrj.com.cn/2021/03/24205232210907.shtml",
    "datetime": "2021-03-24 20:52:09",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：2020年年度报告披露时间变更为3月25日",
    "href": "http://stock.jrj.com.cn/2021/03/19163432164426.shtml",
    "datetime": "2021-03-19 16:34:10",
    "code": "002653"
  },
  {
    "title": "海思科：公司目前营销团队约1000人",
    "href": "http://stock.jrj.com.cn/2021/03/16150532144854.shtml",
    "datetime": "2021-03-16 15:05:21",
    "code": "002653"
  },
  {
    "title": "海思科：FT控股所有非TYK2产品的在研项目所属专利和权益等将转给海思科",
    "href": "http://stock.jrj.com.cn/2021/03/10154032103605.shtml",
    "datetime": "2021-03-10 15:40:24",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：拟出售海外控股子公司暨在研项目TYK2产品 最高有望获1.8亿美元转让款",
    "href": "http://stock.jrj.com.cn/2021/03/08214232093242.shtml",
    "datetime": "2021-03-08 21:42:10",
    "code": "002653"
  },
  {
    "title": "海思科：子公司拟作价1.8亿美元向美国风投公司转让在研项目TYK2产品",
    "href": "http://stock.jrj.com.cn/2021/03/08211932093146.shtml",
    "datetime": "2021-03-08 21:19:47",
    "code": "002653"
  },
  {
    "title": "【龙虎榜】海思科3月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/08180132092102.shtml",
    "datetime": "2021-03-08 18:01:24",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：海思科新加坡公司拟获增资2.69亿元 用于购买HSK3486在中国内地以外专有技术所有权",
    "href": "http://stock.jrj.com.cn/2021/03/05173932079107.shtml",
    "datetime": "2021-03-05 17:39:47",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)与Starton签订奥氮平透皮贴剂合作协议",
    "href": "http://stock.jrj.com.cn/2021/03/01155532050397.shtml",
    "datetime": "2021-03-01 15:55:54",
    "code": "002653"
  },
  {
    "title": "海思科2020年度净利6.18亿增长25.22% 转让控股子公司股权获得收益",
    "href": "http://stock.jrj.com.cn/2021/02/27114432037939.shtml",
    "datetime": "2021-02-27 11:44:37",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)业绩快报：2020年净利升25.22%至6.18亿元",
    "href": "http://stock.jrj.com.cn/2021/02/26164632033424.shtml",
    "datetime": "2021-02-26 16:46:42",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药环泊酚注射液新适应症注册申请获得受理",
    "href": "http://stock.jrj.com.cn/2021/02/17165031974338.shtml",
    "datetime": "2021-02-17 16:50:32",
    "code": "002653"
  },
  {
    "title": "海思科股东易泓16号减持166万股 套现3012.9万",
    "href": "http://stock.jrj.com.cn/2021/02/05205731856363.shtml",
    "datetime": "2021-02-05 20:57:01",
    "code": "002653"
  },
  {
    "title": "【龙虎榜】海思科2月5日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/02/05180131855519.shtml",
    "datetime": "2021-02-05 18:01:42",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：易泓16号减持166万股",
    "href": "http://stock.jrj.com.cn/2021/02/05161631854858.shtml",
    "datetime": "2021-02-05 16:16:04",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：3个药品拟中选第四批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2021/02/04170531849333.shtml",
    "datetime": "2021-02-04 17:05:19",
    "code": "002653"
  },
  {
    "title": "海思科：公司以开发针对肿瘤和自身免疫性疾病的Best-in-class、高选择性且口服有效的蛋白降解类药物为目标",
    "href": "http://stock.jrj.com.cn/2021/02/04163531849116.shtml",
    "datetime": "2021-02-04 16:35:59",
    "code": "002653"
  },
  {
    "title": "[海思科]替格瑞洛片获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2021/02/01000031828806.shtml",
    "datetime": "2021-02-01 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]注射用艾司奥美拉唑钠通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/29000031808664.shtml",
    "datetime": "2021-01-29 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]创新药HSK29116散剂临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2021/01/26000031775827.shtml",
    "datetime": "2021-01-26 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科控股股东王俊民质押100万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2021/01/20195631731078.shtml",
    "datetime": "2021-01-20 19:56:40",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民补充质押100万股",
    "href": "http://stock.jrj.com.cn/2021/01/20160231729003.shtml",
    "datetime": "2021-01-20 16:02:13",
    "code": "002653"
  },
  {
    "title": "[海思科]脂肪乳氨基酸(17)葡萄糖(11%)注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/20000031728088.shtml",
    "datetime": "2021-01-20 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：脂肪乳氨基酸(17)葡萄糖(11%)注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/19161031722065.shtml",
    "datetime": "2021-01-19 16:10:03",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：HSK-3486美国III期临床试验申请获FDA同意",
    "href": "http://stock.jrj.com.cn/2021/01/18115731714119.shtml",
    "datetime": "2021-01-18 11:57:18",
    "code": "002653"
  },
  {
    "title": "[海思科]创新药HSK3486乳状注射液美国Ⅲ期临床试验申请获得FDA同意",
    "href": "http://stock.jrj.com.cn/2021/01/18000031719936.shtml",
    "datetime": "2021-01-18 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科控股股东王俊民质押989.51万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2021/01/15194931701007.shtml",
    "datetime": "2021-01-15 19:49:48",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民质押989.51万股",
    "href": "http://stock.jrj.com.cn/2021/01/15163331699036.shtml",
    "datetime": "2021-01-15 16:33:02",
    "code": "002653"
  },
  {
    "title": "海思科副总经理、董事会秘书王萌增持1万股 耗资约16.3万元",
    "href": "http://stock.jrj.com.cn/2021/01/13214931686491.shtml",
    "datetime": "2021-01-13 21:49:01",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)已获董秘王萌增持1万股",
    "href": "http://stock.jrj.com.cn/2021/01/13162731684454.shtml",
    "datetime": "2021-01-13 16:27:46",
    "code": "002653"
  },
  {
    "title": "[海思科]“知识竞赛强意识,药品安全记心中” PV知识主题竞赛顺利举办",
    "href": "http://stock.jrj.com.cn/2021/01/08000031654778.shtml",
    "datetime": "2021-01-08 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：控股股东及实控人之一范秀莲解押862万股",
    "href": "http://stock.jrj.com.cn/2020/12/30161331605028.shtml",
    "datetime": "2020-12-30 16:13:20",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：王俊民质押2300万股及解押3180万股 范秀莲解押862万股",
    "href": "http://stock.jrj.com.cn/2020/12/23170031554383.shtml",
    "datetime": "2020-12-23 17:00:07",
    "code": "002653"
  },
  {
    "title": "[海思科]磺达肝癸钠注射液获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/12/22000031546522.shtml",
    "datetime": "2020-12-22 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得磺达肝癸钠注射液的药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/12/21160131536506.shtml",
    "datetime": "2020-12-21 16:01:09",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民解除质押573万股及质押展期2210万股",
    "href": "http://stock.jrj.com.cn/2020/12/18161731518845.shtml",
    "datetime": "2020-12-18 16:17:30",
    "code": "002653"
  },
  {
    "title": "[海思科]创新药环泊酚注射液获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/12/18000031519881.shtml",
    "datetime": "2020-12-18 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：获得创新药环泊酚注射液的药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/12/17165831510070.shtml",
    "datetime": "2020-12-17 16:58:31",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：国家药监局批准HSK3486开展“ICU期间镇静”Ⅲ期临试申请",
    "href": "http://stock.jrj.com.cn/2020/12/16175831503382.shtml",
    "datetime": "2020-12-16 17:58:46",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：实控人之一王俊民解押4211万股",
    "href": "http://stock.jrj.com.cn/2020/12/08154631440013.shtml",
    "datetime": "2020-12-08 15:46:39",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科医药集团获得“2020中国医药创新企业100强”等多项荣誉称号",
    "href": "http://stock.jrj.com.cn/2020/12/05000031428914.shtml",
    "datetime": "2020-12-05 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]创新药FTP-198片获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2020/12/02000031391559.shtml",
    "datetime": "2020-12-02 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科控股股东王俊民质押2550万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2020/12/01195531386541.shtml",
    "datetime": "2020-12-01 19:55:26",
    "code": "002653"
  },
  {
    "title": "海思科：子公司签订技术转让合同 拟2.69亿元向下属新加坡公司转让一项专有技术所有权",
    "href": "http://stock.jrj.com.cn/2020/12/01183931386151.shtml",
    "datetime": "2020-12-01 18:39:58",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：全资子公司获盐酸普拉克索缓释片《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/11/30120331375051.shtml",
    "datetime": "2020-11-30 12:03:24",
    "code": "002653"
  },
  {
    "title": "[海思科]盐酸普拉克索缓释片获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/11/30000031376375.shtml",
    "datetime": "2020-11-30 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科控股股东王俊民质押984万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/11/27200931362563.shtml",
    "datetime": "2020-11-27 20:09:55",
    "code": "002653"
  },
  {
    "title": "辽宁药监局公示行政检查 整改涉上海医药海思科子公司",
    "href": "http://stock.jrj.com.cn/2020/11/27173731361499.shtml",
    "datetime": "2020-11-27 17:37:00",
    "code": "002653"
  },
  {
    "title": "海思科2020年前三季度净利4.03亿增长5.1% 其他收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/30213831177100.shtml",
    "datetime": "2020-10-30 21:38:02",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科医药集团荣登“2020中国化学制药 行业优秀企业和优秀产品品牌榜”",
    "href": "http://stock.jrj.com.cn/2020/10/16000031066702.shtml",
    "datetime": "2020-10-16 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]培哚普利叔丁胺片获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/10/14000031050494.shtml",
    "datetime": "2020-10-14 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]创新药HSK3486乳状注射液获批开展“全麻维持”的Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2020/10/14000031050493.shtml",
    "datetime": "2020-10-14 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科公司治理信息披露均违规 实控人王俊民收警示函",
    "href": "http://stock.jrj.com.cn/2020/10/13190831045159.shtml",
    "datetime": "2020-10-13 19:08:00",
    "code": "002653"
  },
  {
    "title": "上市公司和控股股东人员等严重混同 海思科及实控人收警示函",
    "href": "http://stock.jrj.com.cn/2020/10/12201731033832.shtml",
    "datetime": "2020-10-12 20:17:21",
    "code": "002653"
  },
  {
    "title": "海思科6宗违规收警示函 与控股股东人员财务严重混同",
    "href": "http://stock.jrj.com.cn/2020/10/12155631032360.shtml",
    "datetime": "2020-10-12 15:56:00",
    "code": "002653"
  },
  {
    "title": "A股异动 | 海思科(002653.SZ)涨超5% 创新药HSK3486乳状注射液获批开展Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2020/10/12100731030459.shtml",
    "datetime": "2020-10-12 10:07:20",
    "code": "002653"
  },
  {
    "title": "[海思科]创新药HSK3486乳状注射液获得境内生产药品注册《受理通知书》及《药物临床试验批准通知书》",
    "href": "http://stock.jrj.com.cn/2020/10/12000031031126.shtml",
    "datetime": "2020-10-12 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK3486乳状注射液获得受理通知书及药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2020/10/11202231020064.shtml",
    "datetime": "2020-10-11 20:22:10",
    "code": "002653"
  },
  {
    "title": "海思科控股股东郑伟质押2280万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/09/29210330861606.shtml",
    "datetime": "2020-09-29 21:03:30",
    "code": "002653"
  },
  {
    "title": "海思科创新药HSK16149近日获得伦理批件",
    "href": "http://stock.jrj.com.cn/2020/09/15181930756397.shtml",
    "datetime": "2020-09-15 18:19:47",
    "code": "002653"
  },
  {
    "title": "海思科(002653.SZ)：创新药HSK16149胶囊Ⅱ/Ⅲ期临床试验获得伦理批准",
    "href": "http://stock.jrj.com.cn/2020/09/15160730755488.shtml",
    "datetime": "2020-09-15 16:07:30",
    "code": "002653"
  },
  {
    "title": "[海思科]金融知识进万家,争做理性投资者,争做金融好网民——金融知识普及月活动",
    "href": "http://stock.jrj.com.cn/2020/09/15000030755632.shtml",
    "datetime": "2020-09-15 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科拟定增募资不超8.21亿元 用于长效口服降血糖新药项目等",
    "href": "http://stock.jrj.com.cn/2020/09/14213030749903.shtml",
    "datetime": "2020-09-14 21:30:12",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科医药集团获得“2019年度中国医药工业百强企业”等多项荣誉称号",
    "href": "http://stock.jrj.com.cn/2020/09/03000030761600.shtml",
    "datetime": "2020-09-03 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科控股股东范秀莲质押950万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/08/19133130537828.shtml",
    "datetime": "2020-08-19 13:31:09",
    "code": "002653"
  },
  {
    "title": "[海思科]注射用醋酸卡泊芬净获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/08/19000030536951.shtml",
    "datetime": "2020-08-19 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]创新药HSK7653片获得Ⅲ期临床试验伦理批准",
    "href": "http://stock.jrj.com.cn/2020/08/19000030536952.shtml",
    "datetime": "2020-08-19 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]创新药HSK3486乳状注射液获得全麻维持适应症境内生产药品注册《受理通知书》",
    "href": "http://stock.jrj.com.cn/2020/08/19000030536950.shtml",
    "datetime": "2020-08-19 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科2020年上半年净利2.29亿减少2.69% 运营费用增加",
    "href": "http://stock.jrj.com.cn/2020/08/18213230532579.shtml",
    "datetime": "2020-08-18 21:32:26",
    "code": "002653"
  },
  {
    "title": "[海思科]欢迎参加《股东来了》2020投资者权益保护知识竞赛活动",
    "href": "http://stock.jrj.com.cn/2020/08/17000030518136.shtml",
    "datetime": "2020-08-17 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科荣膺“2019年中国医药行业最具影响力榜单”四大奖项",
    "href": "http://stock.jrj.com.cn/2020/08/12000030486122.shtml",
    "datetime": "2020-08-12 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科控股股东范秀莲质押1245万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/07/21194730306572.shtml",
    "datetime": "2020-07-21 19:47:36",
    "code": "002653"
  },
  {
    "title": "海思科控股子公司拟出资1000万美元设立全资子公司",
    "href": "http://stock.jrj.com.cn/2020/07/16215130264332.shtml",
    "datetime": "2020-07-16 21:51:41",
    "code": "002653"
  },
  {
    "title": "海思科股东王俊民质押520万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/05/25215229762441.shtml",
    "datetime": "2020-05-25 21:52:08",
    "code": "002653"
  },
  {
    "title": "海思科控股股东质押520万股公司股份",
    "href": "http://stock.jrj.com.cn/2020/05/25203529762084.shtml",
    "datetime": "2020-05-25 20:35:20",
    "code": "002653"
  },
  {
    "title": "首批国产13价肺炎球菌结合疫苗启动接种 桂林三金、海思科等今日涨停 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/05/20183629723223.shtml",
    "datetime": "2020-05-20 18:36:09",
    "code": "002653"
  },
  {
    "title": "海思科：用于治疗瘙痒症的创新药HSK21542注射液获准临床试验",
    "href": "http://stock.jrj.com.cn/2020/05/14120229669701.shtml",
    "datetime": "2020-05-14 12:02:10",
    "code": "002653"
  },
  {
    "title": "海思科股东王俊民质押1240万股 用于自身生产经营",
    "href": "http://stock.jrj.com.cn/2020/05/13215429663956.shtml",
    "datetime": "2020-05-13 21:54:51",
    "code": "002653"
  },
  {
    "title": "海思科第一季度盈利1.28亿同比增长157.67% 贷款利息增加",
    "href": "http://stock.jrj.com.cn/2020/04/29132229417844.shtml",
    "datetime": "2020-04-29 13:22:29",
    "code": "002653"
  },
  {
    "title": "海思科一季度净利润同比增长157.67%",
    "href": "http://stock.jrj.com.cn/2020/04/28180629406418.shtml",
    "datetime": "2020-04-28 18:06:39",
    "code": "002653"
  },
  {
    "title": "海思科：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292289.shtml",
    "datetime": "2020-04-15 08:00:13",
    "code": "002653"
  },
  {
    "title": "海思科2020年一季度预计净利1.25亿元–1.35亿元 同比增长150%-170%",
    "href": "http://stock.jrj.com.cn/2020/04/14193629285656.shtml",
    "datetime": "2020-04-14 19:36:30",
    "code": "002653"
  },
  {
    "title": "海思科：收到产业发展扶持资金 一季度净利预增150%-170%",
    "href": "http://stock.jrj.com.cn/2020/04/14181229285178.shtml",
    "datetime": "2020-04-14 18:12:00",
    "code": "002653"
  },
  {
    "title": "[海思科]抗击疫情,海思科“再”行动!",
    "href": "http://stock.jrj.com.cn/2020/04/13000029275644.shtml",
    "datetime": "2020-04-13 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科：再捐100万元 支持湖北抗疫斗争",
    "href": "http://stock.jrj.com.cn/2020/04/01223729171652.shtml",
    "datetime": "2020-04-01 22:37:00",
    "code": "002653"
  },
  {
    "title": "终止可转债 海思科拟定增募资10亿投入新项目和“补血”",
    "href": "http://stock.jrj.com.cn/2020/03/13215129023024.shtml",
    "datetime": "2020-03-13 21:51:54",
    "code": "002653"
  },
  {
    "title": "终止发行可转债 海思科拟定增募资不超10亿元加码主业",
    "href": "http://stock.jrj.com.cn/2020/03/13185229021673.shtml",
    "datetime": "2020-03-13 18:52:00",
    "code": "002653"
  },
  {
    "title": "海思科：终止公开发行可转债 拟定增募资不超10.02亿元",
    "href": "http://stock.jrj.com.cn/2020/03/13182029021397.shtml",
    "datetime": "2020-03-13 18:20:00",
    "code": "002653"
  },
  {
    "title": "海思科：终止公开发行可转换公司债券",
    "href": "http://stock.jrj.com.cn/2020/03/13170729020822.shtml",
    "datetime": "2020-03-13 17:07:32",
    "code": "002653"
  },
  {
    "title": "海思科：拟定增募资不超10亿元 终止公开发行可转债",
    "href": "http://stock.jrj.com.cn/2020/03/13170529020816.shtml",
    "datetime": "2020-03-13 17:05:41",
    "code": "002653"
  },
  {
    "title": "海思科2019年净利润同比增长50.20%",
    "href": "http://stock.jrj.com.cn/2020/02/28210028917192.shtml",
    "datetime": "2020-02-28 21:00:26",
    "code": "002653"
  },
  {
    "title": "海思科2019年净利5.01亿增长50% 销量同比稳健增长",
    "href": "http://stock.jrj.com.cn/2020/02/28183928916064.shtml",
    "datetime": "2020-02-28 18:39:21",
    "code": "002653"
  },
  {
    "title": "海思科向中国银行山南分行申请授信提供抵押担保 授信额度为1.5亿元",
    "href": "http://stock.jrj.com.cn/2020/02/25213128892505.shtml",
    "datetime": "2020-02-25 21:31:51",
    "code": "002653"
  },
  {
    "title": "海思科：创新药注射液新药申请获受理",
    "href": "http://stock.jrj.com.cn/2020/02/24120428881286.shtml",
    "datetime": "2020-02-24 12:04:38",
    "code": "002653"
  },
  {
    "title": "转型创新药添加底气 海思科2020年业绩或续增25%",
    "href": "http://stock.jrj.com.cn/2020/02/21084728869309.shtml",
    "datetime": "2020-02-21 08:47:00",
    "code": "002653"
  },
  {
    "title": "海思科：环泊酚乳状注射液拟纳入优先审评",
    "href": "http://stock.jrj.com.cn/2020/02/20162828862960.shtml",
    "datetime": "2020-02-20 16:28:21",
    "code": "002653"
  },
  {
    "title": "海思科：满负荷生产 已向疫区发运注射用甲泼尼龙琥珀酸钠90万瓶",
    "href": "http://stock.jrj.com.cn/2020/02/10103328801421.shtml",
    "datetime": "2020-02-10 10:33:00",
    "code": "002653"
  },
  {
    "title": "[海思科]共克时艰,海思科战“疫”在行动",
    "href": "http://stock.jrj.com.cn/2020/02/08000028799367.shtml",
    "datetime": "2020-02-08 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科：获得创新药环泊酚乳状注射液《受理通知书》",
    "href": "http://stock.jrj.com.cn/2020/01/19222228702603.shtml",
    "datetime": "2020-01-19 22:22:35",
    "code": "002653"
  },
  {
    "title": "海思科：达比加群酯胶囊获临床试验受理通知书",
    "href": "http://stock.jrj.com.cn/2020/01/16181128687690.shtml",
    "datetime": "2020-01-16 18:11:00",
    "code": "002653"
  },
  {
    "title": "海思科：达比加群酯胶囊获得临床试验受理通知书",
    "href": "http://stock.jrj.com.cn/2020/01/16173128687544.shtml",
    "datetime": "2020-01-16 17:31:00",
    "code": "002653"
  },
  {
    "title": "海思科：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/13164028667781.shtml",
    "datetime": "2020-01-13 16:40:02",
    "code": "002653"
  },
  {
    "title": "海思科：2019年度净利同比预增50%-56%",
    "href": "http://stock.jrj.com.cn/2020/01/13155328667521.shtml",
    "datetime": "2020-01-13 15:53:27",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科医药集团荣膺“2018年度(首届)全国百家优秀民营医药商业流通企业”称号",
    "href": "http://stock.jrj.com.cn/2020/01/03000028625456.shtml",
    "datetime": "2020-01-03 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科医药集团荣获制药行业企业信用评级AAA级别",
    "href": "http://stock.jrj.com.cn/2020/01/02000028617386.shtml",
    "datetime": "2020-01-02 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科股东范秀莲质押862万股",
    "href": "http://stock.jrj.com.cn/2020/01/01231728614304.shtml",
    "datetime": "2020-01-01 23:17:36",
    "code": "002653"
  },
  {
    "title": "海思科获得9000万扶持资金 前三季度获利1.33亿",
    "href": "http://stock.jrj.com.cn/2019/12/30161328604118.shtml",
    "datetime": "2019-12-30 16:13:46",
    "code": "002653"
  },
  {
    "title": "海思科获西藏山南市幸福家园建设管理局9725万元扶持资金",
    "href": "http://stock.jrj.com.cn/2019/12/30100128602200.shtml",
    "datetime": "2019-12-30 10:01:05",
    "code": "002653"
  },
  {
    "title": "海思科：一类新药HSK21542注射液获得准临床试验",
    "href": "http://stock.jrj.com.cn/2019/12/24175028579994.shtml",
    "datetime": "2019-12-24 17:50:10",
    "code": "002653"
  },
  {
    "title": "海思科：一类新药HSK21542注射液获准临床试验",
    "href": "http://stock.jrj.com.cn/2019/12/24172728579921.shtml",
    "datetime": "2019-12-24 17:27:00",
    "code": "002653"
  },
  {
    "title": "海思科收警示函 计划不少于1亿股份回购实际为0",
    "href": "http://stock.jrj.com.cn/2019/12/24161828579682.shtml",
    "datetime": "2019-12-24 16:18:00",
    "code": "002653"
  },
  {
    "title": "海思科获得复方氨基酸注射液（18AA-IX）药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/22191128568402.shtml",
    "datetime": "2019-12-22 19:11:03",
    "code": "002653"
  },
  {
    "title": "海思科：全资子公司复方氨基酸注射液（18AA-IX）药品注册获批",
    "href": "http://stock.jrj.com.cn/2019/12/22184128568362.shtml",
    "datetime": "2019-12-22 18:41:56",
    "code": "002653"
  },
  {
    "title": "海思科：获得复方氨基酸注射液（18AA-IX）药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/22164028568197.shtml",
    "datetime": "2019-12-22 16:40:00",
    "code": "002653"
  },
  {
    "title": "海思科：获得复方氨基酸注射液药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/22163228568182.shtml",
    "datetime": "2019-12-22 16:32:56",
    "code": "002653"
  },
  {
    "title": "[海思科]思瑞雪精氨酸谷氨酸注射液通过谈判纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/12/06000028501101.shtml",
    "datetime": "2019-12-06 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科：子公司获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/12/04155928488970.shtml",
    "datetime": "2019-12-04 15:59:17",
    "code": "002653"
  },
  {
    "title": "海思科一股未买回购终止 三成利润来自政府补贴",
    "href": "http://stock.jrj.com.cn/2019/12/04082128486677.shtml",
    "datetime": "2019-12-04 08:21:13",
    "code": "002653"
  },
  {
    "title": "多家公司抛出亿元回购计划 海思科最终“零回购”收场",
    "href": "http://stock.jrj.com.cn/2019/12/02224928480018.shtml",
    "datetime": "2019-12-02 22:49:00",
    "code": "002653"
  },
  {
    "title": "“小恒瑞”海思科终止回购计划！医保谈判降价幅度最大 利空仍在发酵",
    "href": "http://stock.jrj.com.cn/2019/12/02172828478449.shtml",
    "datetime": "2019-12-02 17:28:01",
    "code": "002653"
  },
  {
    "title": "海思科：股份回购期届满 并终止实施回购",
    "href": "http://stock.jrj.com.cn/2019/12/02170128478335.shtml",
    "datetime": "2019-12-02 17:01:00",
    "code": "002653"
  },
  {
    "title": "海思科：回购股份期限已届满 尚未回购1股",
    "href": "http://stock.jrj.com.cn/2019/12/02165628478279.shtml",
    "datetime": "2019-12-02 16:56:35",
    "code": "002653"
  },
  {
    "title": "海思科：公司独家产品精氨酸谷氨酸注射液被纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28164628463746.shtml",
    "datetime": "2019-11-28 16:46:37",
    "code": "002653"
  },
  {
    "title": "海思科：独家产品精氨酸谷氨酸注射被纳入医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28164228463737.shtml",
    "datetime": "2019-11-28 16:42:34",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科荣获“新中国70周年·中国医药卫生企业功勋单位”评选活动“技术创新奖”",
    "href": "http://stock.jrj.com.cn/2019/11/21000028433246.shtml",
    "datetime": "2019-11-21 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科股东范秀莲质押1000万股 上半年净利同比增长62%",
    "href": "http://stock.jrj.com.cn/2019/11/19204028421679.shtml",
    "datetime": "2019-11-19 20:40:51",
    "code": "002653"
  },
  {
    "title": "医保谈判糖尿病药大杀价 海思科股价跌停通化东宝跳水",
    "href": "http://stock.jrj.com.cn/2019/11/13134028392812.shtml",
    "datetime": "2019-11-13 13:40:48",
    "code": "002653"
  },
  {
    "title": "海思科股东富盈50号减持450万股 套现约1.02亿元",
    "href": "http://stock.jrj.com.cn/2019/11/07183628366898.shtml",
    "datetime": "2019-11-07 18:36:32",
    "code": "002653"
  },
  {
    "title": "海思科第三季度盈利1.48亿 同比下滑6%",
    "href": "http://stock.jrj.com.cn/2019/10/27195528305613.shtml",
    "datetime": "2019-10-27 19:55:26",
    "code": "002653"
  },
  {
    "title": "海思科：获得创新药HSK21542注射液新药申请《受理通知书》",
    "href": "http://stock.jrj.com.cn/2019/10/20163328272103.shtml",
    "datetime": "2019-10-20 16:33:00",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科荣获“2019年中国化学制药行业优秀企业和优秀产品品牌”称号",
    "href": "http://stock.jrj.com.cn/2019/10/12000028239965.shtml",
    "datetime": "2019-10-12 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科股东范秀莲质押3200万股 公司去年净利同比增长62%",
    "href": "http://stock.jrj.com.cn/2019/08/22105828015533.shtml",
    "datetime": "2019-08-22 10:58:46",
    "code": "002653"
  },
  {
    "title": "海思科：HSK3486乳状注射液拟纳入优先审评程序",
    "href": "http://stock.jrj.com.cn/2019/08/21165328011043.shtml",
    "datetime": "2019-08-21 16:53:00",
    "code": "002653"
  },
  {
    "title": "海思科：关于首期限制性股票激励计划首次授予完成的公告",
    "href": "http://stock.jrj.com.cn/2019/08/18162027992286.shtml",
    "datetime": "2019-08-18 16:20:00",
    "code": "002653"
  },
  {
    "title": "医药板块震荡上扬 通化金马海思科等涨停",
    "href": "http://stock.jrj.com.cn/hotstock/2019/08/14144127975368.shtml",
    "datetime": "2019-08-14 14:41:00",
    "code": "002653"
  },
  {
    "title": "海思科股东申萍解除质押1100万股",
    "href": "http://stock.jrj.com.cn/2019/08/08182627948604.shtml",
    "datetime": "2019-08-08 18:26:09",
    "code": "002653"
  },
  {
    "title": "海思科：上半年净利2.35亿元 同比增长62%",
    "href": "http://stock.jrj.com.cn/2019/08/05222027932218.shtml",
    "datetime": "2019-08-05 22:20:35",
    "code": "002653"
  },
  {
    "title": "海思科2019年上半年盈利2.4亿 加快新品种招标",
    "href": "http://stock.jrj.com.cn/2019/08/05215127932148.shtml",
    "datetime": "2019-08-05 21:51:30",
    "code": "002653"
  },
  {
    "title": "海思科：创新药HSK3486乳状注射液新药获受理",
    "href": "http://stock.jrj.com.cn/2019/07/30163627904164.shtml",
    "datetime": "2019-07-30 16:36:35",
    "code": "002653"
  },
  {
    "title": "海思科：注射用甲泼尼龙琥珀酸钠一致性评价获获药监局受理",
    "href": "http://stock.jrj.com.cn/2019/07/17170127852627.shtml",
    "datetime": "2019-07-17 17:01:40",
    "code": "002653"
  },
  {
    "title": "海思科：注射用甲泼尼龙琥珀酸钠一致性评价获受理",
    "href": "http://stock.jrj.com.cn/2019/07/17165727852606.shtml",
    "datetime": "2019-07-17 16:57:00",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科荣获“2018年度中国化药企业TOP100企业”称号",
    "href": "http://stock.jrj.com.cn/2019/07/17000027852685.shtml",
    "datetime": "2019-07-17 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科股东王俊民质押692万股 公司去年净利同比增长40%",
    "href": "http://stock.jrj.com.cn/2019/07/12072127829959.shtml",
    "datetime": "2019-07-12 07:21:05",
    "code": "002653"
  },
  {
    "title": "海思科：子公司将独家代理印度Glenmark所产阿瑞匹坦胶囊",
    "href": "http://stock.jrj.com.cn/2019/07/02184527786972.shtml",
    "datetime": "2019-07-02 18:45:36",
    "code": "002653"
  },
  {
    "title": "上半年业绩预增50%-65% 海思科连续两日涨停",
    "href": "http://stock.jrj.com.cn/2019/07/02101227784857.shtml",
    "datetime": "2019-07-02 10:12:43",
    "code": "002653"
  },
  {
    "title": "海思科：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/06/30202027774413.shtml",
    "datetime": "2019-06-30 20:20:00",
    "code": "002653"
  },
  {
    "title": "海思科：上半年业绩预增50%-65%",
    "href": "http://stock.jrj.com.cn/2019/06/30162127774095.shtml",
    "datetime": "2019-06-30 16:21:00",
    "code": "002653"
  },
  {
    "title": "海思科：2017年第一期员工持股计划终止",
    "href": "http://stock.jrj.com.cn/2019/06/26164827758939.shtml",
    "datetime": "2019-06-26 16:48:00",
    "code": "002653"
  },
  {
    "title": "销售费用增长76%？ 海思科：两票制后医药销售模式发生重大变化",
    "href": "http://stock.jrj.com.cn/2019/06/19120327724248.shtml",
    "datetime": "2019-06-19 12:03:25",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科荣膺“2018年度中国医药行业最具影响力榜单”五大奖项",
    "href": "http://stock.jrj.com.cn/2019/06/06000027672764.shtml",
    "datetime": "2019-06-06 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]欢迎参加《股东来了》2019投资者权益知识竞赛活动",
    "href": "http://stock.jrj.com.cn/2019/06/04000027662185.shtml",
    "datetime": "2019-06-04 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科：获培哚普利叔丁胺片受理通知书",
    "href": "http://stock.jrj.com.cn/2019/06/03173027658487.shtml",
    "datetime": "2019-06-03 17:30:00",
    "code": "002653"
  },
  {
    "title": "海思科：获得培哚普利叔丁胺片受理通知书",
    "href": "http://stock.jrj.com.cn/2019/06/03165527658193.shtml",
    "datetime": "2019-06-03 16:55:02",
    "code": "002653"
  },
  {
    "title": "海思科：丙泊酚中/长链脂肪乳注射液获药品注册受理通知书",
    "href": "http://stock.jrj.com.cn/2019/06/02175327654011.shtml",
    "datetime": "2019-06-02 17:53:00",
    "code": "002653"
  },
  {
    "title": "海思科股东王俊民质押1311万股 公司去年净利同比增长40%",
    "href": "http://stock.jrj.com.cn/2019/05/26091227623021.shtml",
    "datetime": "2019-05-26 09:12:56",
    "code": "002653"
  },
  {
    "title": "海思科两药品获得一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2019/05/21181027602487.shtml",
    "datetime": "2019-05-21 18:10:03",
    "code": "002653"
  },
  {
    "title": "海思科：两药品获得一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2019/05/21165827601971.shtml",
    "datetime": "2019-05-21 16:58:00",
    "code": "002653"
  },
  {
    "title": "海思科：获得盐酸帕洛诺司琼注射液一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2019/05/21164127601829.shtml",
    "datetime": "2019-05-21 16:41:33",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科携重磅品种1.1类静脉麻醉创新药思舒宁及独家止吐药物立必复亮相2019 CAA年会",
    "href": "http://stock.jrj.com.cn/2019/04/26000027492126.shtml",
    "datetime": "2019-04-26 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科2019年第一季度营收增长76% 净利4982万元 董事长王俊民上年末持股4亿股",
    "href": "http://stock.jrj.com.cn/2019/04/24153727474652.shtml",
    "datetime": "2019-04-24 15:37:55",
    "code": "002653"
  },
  {
    "title": "[海思科]盐酸乙酰左卡尼汀片学术结缘糖尿病领域专家",
    "href": "http://stock.jrj.com.cn/2019/04/18000027425927.shtml",
    "datetime": "2019-04-18 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]2019年湖北省医学会消化病学/消化内镜分会联合学术年会成功举办",
    "href": "http://stock.jrj.com.cn/2019/04/16000027408055.shtml",
    "datetime": "2019-04-16 00:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]川海召开ERP项目启动大会",
    "href": "http://stock.jrj.com.cn/2019/04/11000027366382.shtml",
    "datetime": "2019-04-11 00:00:00",
    "code": "002653"
  },
  {
    "title": "海思科：富马酸替诺福韦二吡呋酯片获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/04/09170627354971.shtml",
    "datetime": "2019-04-09 17:06:04",
    "code": "002653"
  },
  {
    "title": "海思科：获美国企业eXIthera抗血凝产品中国许可权",
    "href": "http://stock.jrj.com.cn/2019/04/01180027295335.shtml",
    "datetime": "2019-04-01 18:00:00",
    "code": "002653"
  },
  {
    "title": "[海思科]海思科多拉司琼江苏省麻醉年会卫星会顺利召开",
    "href": "http://stock.jrj.com.cn/2019/04/01000027296180.shtml",
    "datetime": "2019-04-01 00:00:00",
    "code": "002653"
  }
]